results in slower rates of spinal fusion on radiographs over 2 years compared to on-demand NSAID use is inconsistent, with results of one trial of celecoxib suggesting less progression with continuous use, and one trial of diclofenac indicating no difference in progression http:// onlin Active disease Disease causing symptoms at an unacceptably bothersome level to the patient and judged by the examining clinician to be due to inflammation. Stable disease Disease that was asymptomatic or causing symptoms but at an acceptable level as reported by the patient. A minimum of 6 months was required to qualify as clinically stable. Primary nonresponse Absence of a clinically meaningful improvement in disease activity over the 3 to 6 months after treatment initiation, not related to toxicity or poor adherence. Secondary nonresponse Recurrence of ankylosing spondylitis activity, not due to treatment interruption or poor adherence, after having a sustained clinically meaningful improvement on